Ranger Investment Management L.P. Has $30.80 Million Stock Position in Mesa Laboratories, Inc. (NASDAQ:MLAB)

Ranger Investment Management L.P. lowered its stake in shares of Mesa Laboratories, Inc. (NASDAQ:MLAB - Free Report) by 1.9% during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 233,555 shares of the medical instruments supplier's stock after selling 4,635 shares during the period. Mesa Laboratories makes up 1.9% of Ranger Investment Management L.P.'s portfolio, making the stock its 18th biggest position. Ranger Investment Management L.P. owned approximately 4.30% of Mesa Laboratories worth $30,799,000 as of its most recent filing with the Securities and Exchange Commission.

Several other institutional investors also recently modified their holdings of MLAB. Pacer Advisors Inc. lifted its holdings in shares of Mesa Laboratories by 4.3% in the fourth quarter. Pacer Advisors Inc. now owns 1,755 shares of the medical instruments supplier's stock valued at $231,000 after purchasing an additional 73 shares in the last quarter. Berry Wealth Group LP boosted its stake in shares of Mesa Laboratories by 5.3% during the 4th quarter. Berry Wealth Group LP now owns 1,657 shares of the medical instruments supplier's stock worth $219,000 after buying an additional 83 shares during the last quarter. FMR LLC grew its holdings in shares of Mesa Laboratories by 34.1% in the 3rd quarter. FMR LLC now owns 393 shares of the medical instruments supplier's stock valued at $51,000 after acquiring an additional 100 shares in the last quarter. Los Angeles Capital Management LLC increased its position in shares of Mesa Laboratories by 3.0% in the fourth quarter. Los Angeles Capital Management LLC now owns 3,394 shares of the medical instruments supplier's stock valued at $448,000 after acquiring an additional 100 shares during the last quarter. Finally, Alliancebernstein L.P. raised its holdings in Mesa Laboratories by 2.6% during the fourth quarter. Alliancebernstein L.P. now owns 5,584 shares of the medical instruments supplier's stock worth $736,000 after acquiring an additional 141 shares in the last quarter. 90.60% of the stock is currently owned by institutional investors and hedge funds.

Remove Ads

Insider Activity at Mesa Laboratories

In other Mesa Laboratories news, CEO Gary M. Owens sold 21,000 shares of the firm's stock in a transaction dated Wednesday, March 19th. The shares were sold at an average price of $123.91, for a total value of $2,602,110.00. Following the transaction, the chief executive officer now directly owns 43,337 shares of the company's stock, valued at $5,369,887.67. This trade represents a 32.64 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. 4.40% of the stock is currently owned by corporate insiders.

Mesa Laboratories Stock Down 1.9 %

Shares of NASDAQ MLAB traded down $2.19 during trading hours on Monday, hitting $112.38. The company had a trading volume of 22,735 shares, compared to its average volume of 38,726. Mesa Laboratories, Inc. has a 1-year low of $83.68 and a 1-year high of $155.12. The company has a quick ratio of 0.53, a current ratio of 0.71 and a debt-to-equity ratio of 0.61. The firm's 50 day moving average is $130.23 and its 200-day moving average is $128.21. The stock has a market capitalization of $610.67 million, a P/E ratio of -2.43 and a beta of 0.92.

Mesa Laboratories (NASDAQ:MLAB - Get Free Report) last released its quarterly earnings data on Tuesday, February 4th. The medical instruments supplier reported $2.07 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $1.41 by $0.66. Mesa Laboratories had a positive return on equity of 30.23% and a negative net margin of 104.92%. On average, analysts expect that Mesa Laboratories, Inc. will post 8 earnings per share for the current fiscal year.

Mesa Laboratories Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Monday, June 16th. Investors of record on Friday, May 30th will be issued a dividend of $0.16 per share. The ex-dividend date is Friday, May 30th. This represents a $0.64 annualized dividend and a yield of 0.57%. Mesa Laboratories's payout ratio is currently -1.38%.

Mesa Laboratories Profile

Mesa Laboratories, Inc develops, designs, manufactures, sells, and services life sciences tools and quality control products and services in North America, Europe, the Asia Pacific, and internationally. The Sterilization and Disinfection Control segment offers biological, chemical, and cleaning indicators, used to assess the effectiveness of sterilization decontamination, disinfection, and cleaning processes in the pharmaceutical, medical device, and healthcare industries.